FMC (NYSE:FMC) Posts Earnings Results, Misses Estimates By $4.49 EPS

FMC (NYSE:FMC) issued its quarterly earnings data on Thursday. The basic materials company reported ($4.41) EPS for the quarter, missing the consensus estimate of $0.08 by ($4.49), FiscalAI reports. FMC had a negative net margin of 151.18% and a negative return on equity of 23.12%. The business had revenue of $105.90 million for the quarter, compared to analysts’ expectations of $487.63 million. During the same quarter in the prior year, the company posted $0.89 EPS. The business’s revenue for the quarter was down 80.5% on a year-over-year basis.

FMC Trading Up 30.7%

FMC opened at $6.21 on Friday. FMC has a 52 week low of $4.37 and a 52 week high of $18.29. The company has a quick ratio of 1.48, a current ratio of 1.99 and a debt-to-equity ratio of 2.38. The business has a fifty day simple moving average of $9.13 and a 200-day simple moving average of $12.46. The firm has a market cap of $777.68 million, a P/E ratio of -0.19 and a beta of 0.45.

Key Stories Impacting FMC

Here are the key news stories impacting FMC this week:

• Positive Sentiment: Management forecast at least $650 million in adjusted EBITDA for 2027, suggesting the company expects its commercial and pricing changes to improve profitability after the current inventory reset. FMC forecasts 2027 adjusted EBITDA and channel-inventory actions
• Positive Sentiment: Operating cash flow was positive at $7 million, while free cash flow improved year over year despite remaining negative. The company also detailed actions intended to remove approximately $672 million of channel inventory and address higher-priced products held by customers.
• Neutral Sentiment: FMC’s earnings call focused on executing the commercial reset and rebuilding demand, with investors seeking evidence that the inventory and pricing issues are temporary rather than a structural deterioration in the agricultural-chemicals business. FMC Q3 2026 earnings call transcript
• Negative Sentiment: Third-quarter revenue plunged to $106 million from $542 million a year earlier, with commercial actions reducing sales by approximately $639 million. Adjusted EBITDA was negative $559 million, and adjusted loss per share was $4.41 versus earnings of $0.89 a year ago. FMC reports third-quarter 2026 results
• Negative Sentiment: FMC lowered its fourth-quarter forecast to revenue of $1.04 billion–$1.14 billion, adjusted EBITDA of $210 million–$230 million and adjusted EPS of $0.56–$0.70. Full-year free cash flow is now expected to range from negative $350 million to negative $150 million. FMC Q3 earnings miss and outlook reduction
• Negative Sentiment: A law firm announced an investigation into potential investor claims following the earnings disclosures, adding legal and reputational risk. Pomerantz investigation into FMC

Wall Street Analysts Forecast Growth

FMC has been the subject of a number of recent analyst reports. Morgan Stanley lowered their target price on shares of FMC from $15.50 to $12.00 and set an “equal weight” rating for the company in a research note on Friday, July 31st. UBS Group dropped their target price on FMC from $12.00 to $10.00 and set a “neutral” rating on the stock in a report on Monday, October 5th. BMO Capital Markets cut their price objective on shares of FMC from $11.00 to $7.50 and set a “market perform” rating for the company in a report on Friday, October 16th. KeyCorp began coverage on FMC in a research note on Friday, September 11th. They set an “overweight” rating and a $16.00 target price for the company. Finally, Seaport Research Partners set a $21.00 price objective on FMC in a report on Tuesday, August 4th. Three equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and five have assigned a Sell rating to the company. Based on data from MarketBeat.com, FMC presently has an average rating of “Reduce” and a consensus price target of $11.25.

About FMC

FMC Corporation (NYSE: FMC) is an agricultural sciences company that develops and markets crop protection products and technologies. Its portfolio is designed to help farmers manage weeds, insects and diseases that can affect crop yields and quality.

The company’s products include herbicides, insecticides, fungicides, biological crop protection products and seed treatment solutions. FMC also develops crop health technologies and digital tools intended to support more precise and efficient agricultural applications.

FMC serves farmers, agricultural retailers and distributors in major farming regions around the world, with products used across a broad range of crops.